S Truant, O Scatton, S Dokmak, J-M Regimbeau, V Lucidi, A Laurent, R Gauzolino, C Castro Benitez, A Pequignot, V Donckier, C Lim, M-L Blanleuil, R Brustia, Y-P Le Treut, O Soubrane, D Azoulay, O Farges, R Adam, F-R Pruvot
BACKGROUND: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) was recently developed to induce rapid hypertrophy and reduce post-hepatectomy liver failure in patients with insufficient remnant liver volume (RLV). However, mortality rates >12% have been reported. This study aimed to analyze the perioperative course of ALPPS and to identify factors associated with morbi-mortality. METHODS: Between April 2011 and September 2013, 62 patients operated in 9 Franco-Belgian hepatobiliary centres underwent ALPPS for colorectal metastases (N = 50) or primary tumors, following chemotherapy (N = 50) and/or portal vein embolization (PVE; N = 9)...
May 2015: European Journal of Surgical Oncology